These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23739498)

  • 1. [Clinical characteristics and treatment of polyneuropathy developed after chemotherapy].
    Kholodova NB; Sotnikov VM; Dobrovol'skaia NIu; Ponkratova IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):20-4. PubMed ID: 23739498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and electromyography characteristics of chemotherapy-induced polyneuropathy].
    Kholodova NB; Ponkratova YA; Sinkin MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):59-66. PubMed ID: 29053122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.
    Zedan AH; Vilholm OJ
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):193-200. PubMed ID: 24796774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced peripheral neurotoxicity.
    Cavaletti G; Marmiroli P
    Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Foot Bathing and Foot Massage in Chemotherapy-Induced Peripheral Neuropathy.
    Park R; Park C
    Cancer Nurs; 2015; 38(3):239-47. PubMed ID: 25275582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
    Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB
    J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced polyneuropathy in cancer care-the patient perspective.
    Prager K; Passig K; Micke O; Zomorodbakhsch B; Keinki C; Hübner J
    Support Care Cancer; 2023 Mar; 31(4):235. PubMed ID: 36971861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
    Velasco R; Bruna J
    Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
    Beijers AJ; Jongen JL; Vreugdenhil G
    Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity.
    Cavaletti G; Marmiroli P
    Expert Opin Pharmacother; 2018 Feb; 19(2):113-121. PubMed ID: 29219629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study.
    Rick O; von Hehn U; Mikus E; Dertinger H; Geiger G
    Bioelectromagnetics; 2017 Feb; 38(2):85-94. PubMed ID: 27657350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy.
    Grim J; Ticha A; Hyspler R; Valis M; Zadak Z
    Nutrients; 2017 May; 9(6):. PubMed ID: 28587059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
    Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
    Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.
    Zedan AH; Hansen TF; Fex Svenningsen A; Vilholm OJ
    Clin Colorectal Cancer; 2014 Jun; 13(2):73-80. PubMed ID: 24365057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
    Cavaletti G; Frigeni B; Lanzani F; Mattavelli L; Susani E; Alberti P; Cortinovis D; Bidoli P
    Eur J Cancer; 2010 Feb; 46(3):479-94. PubMed ID: 20045310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Recovery of Balance Control: Association With Chemotherapy-Induced Peripheral Neuropathy in Pediatric Oncology.
    Gilchrist LS; Tanner LR
    Pediatr Phys Ther; 2018 Apr; 30(2):119-124. PubMed ID: 29498961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-treatment-induced neurotoxicity--focus on newer treatments.
    Stone JB; DeAngelis LM
    Nat Rev Clin Oncol; 2016 Feb; 13(2):92-105. PubMed ID: 26391778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced neuropathy: A comprehensive survey.
    Miltenburg NC; Boogerd W
    Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.